These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dysfunction of p53 pathway in human colorectal cancer: analysis of p53 gene mutation and the expression of the p53-associated factors p14ARF, p33ING1, p21WAF1 and MDM2. Tachibana M, Kawamata H, Fujimori T, Omotehara F, Horiuchi H, Ohkura Y, Igarashi S, Kotake K, Kubota K. Int J Oncol; 2004 Oct; 25(4):913-20. PubMed ID: 15375540 [Abstract] [Full Text] [Related]
4. 5' cytosine-phospho-guanine island methylation is responsible for p14ARF inactivation and inversely correlates with p53 overexpression in resected non-small cell lung cancer. Hsu HS, Wang YC, Tseng RC, Chang JW, Chen JT, Shih CM, Chen CY, Wang YC. Clin Cancer Res; 2004 Jul 15; 10(14):4734-41. PubMed ID: 15269146 [Abstract] [Full Text] [Related]
5. Alterations of the p16-pRb pathway and the chromosome locus 9p21-22 in non-small-cell lung carcinomas: relationship with p53 and MDM2 protein expression. Gorgoulis VG, Zacharatos P, Kotsinas A, Liloglou T, Kyroudi A, Veslemes M, Rassidakis A, Halazonetis TD, Field JK, Kittas C. Am J Pathol; 1998 Dec 15; 153(6):1749-65. PubMed ID: 9846966 [Abstract] [Full Text] [Related]
6. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas. Rieske P, Bartkowiak JK, Szadowska AM, Olborski B, Harezga-Bal B, Debiec-Rychter M. J Exp Clin Cancer Res; 1999 Sep 15; 18(3):403-16. PubMed ID: 10606188 [Abstract] [Full Text] [Related]
7. Associations of MDM2 SNP309, transcriptional activity, mRNA expression, and survival in stage I non-small-cell lung cancer patients with wild-type p53 tumors. Chien WP, Wong RH, Cheng YW, Chen CY, Lee H. Ann Surg Oncol; 2010 Apr 15; 17(4):1194-202. PubMed ID: 19941079 [Abstract] [Full Text] [Related]
9. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Lindström MS, Klangby U, Wiman KG. Oncogene; 2001 Apr 19; 20(17):2171-7. PubMed ID: 11360201 [Abstract] [Full Text] [Related]
10. MDM2 mRNA expression is a favorable prognostic factor in non-small-cell lung cancer. Ko JL, Cheng YW, Chang SL, Su JM, Chen CY, Lee H. Int J Cancer; 2000 May 20; 89(3):265-70. PubMed ID: 10861503 [Abstract] [Full Text] [Related]
11. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Eymin B, Gazzeri S, Brambilla C, Brambilla E. Oncogene; 2002 Apr 18; 21(17):2750-61. PubMed ID: 11965548 [Abstract] [Full Text] [Related]
12. Aberrant expression of pRb, p16, p14ARF, MDM2, p21 and p53 in squamous cell carcinomas of lung. Xue Q, Sano T, Kashiwabara K, Oyama T, Nakajima T. Jpn J Cancer Res; 2001 Mar 18; 92(3):285-92. PubMed ID: 11267938 [Abstract] [Full Text] [Related]
18. A molecular and immunohistochemical study of the MDM2 protein isoforms and p53 gene product in bronchogenic carcinoma. Gorgoulis VG, Zoumpourlis V, Rassidakis GZ, Karameris A, Rassidakis AN, Spandidos DA, Kittas C. J Pathol; 1996 Oct 18; 180(2):129-37. PubMed ID: 8976869 [Abstract] [Full Text] [Related]
19. Expression of the p14ARF tumor suppressor predicts survival in acute myeloid leukemia. Müller-Tidow C, Metzelder SK, Buerger H, Packeisen J, Ganser A, Heil G, Kügler K, Adigüzel G, Schwäble J, Steffen B, Ludwig WD, Heinecke A, Büchner T, Berdel WE, Serve H. Leukemia; 2004 Apr 18; 18(4):720-6. PubMed ID: 14973498 [Abstract] [Full Text] [Related]